Ibuprofen API Market Trends

Ibuprofen API Market Trends

• The increasing prevalence of pain conditions globally has emerged as a substantial growth driver for the market.
   
• Conditions such as arthritis, back pain, inflammatory disorders, and other chronic pain conditions are becoming common, increasing the demand for effective pain management drugs. For instance, as per the Global RA Network, 2021, more than 350 million people have arthritis globally. Similarly, based on data from the National Health Interview Survey (NHIS), during 2019 – 2021, an estimated 53.2 million adults in the U.S. were diagnosed with some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia.
   
• Such high prevalence of pain disorders increases the demand for effective pain medications, thereby driving the ibuprofen API industry.
   
• Ibuprofen is a widely used nonsteroidal anti-inflammatory drug (NSAID) and is favored for its effectiveness in relieving mild to moderate pain, reducing inflammation, and lowering fever.
   
• The drug's popularity stems from its broad applicability across age groups and its relatively low incidence of side effects compared to other pain medications.
   
• Thus, as the global population continues to age and chronic diseases become more prevalent, the demand for ibuprofen API is expected to grow.